APA (7th ed.) Citation

Rajesh K. Kasam, Rajesh K. Kasam, Rajesh K. Kasam, Geereddy B. Reddy, Anil G. Jegga, Anil G. Jegga, . . . Satish K. Madala. (2019). Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Rajesh K. Kasam, Rajesh K. Kasam, Rajesh K. Kasam, Geereddy B. Reddy, Anil G. Jegga, Anil G. Jegga, Satish K. Madala, and Satish K. Madala. Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy. Frontiers Media S.A., 2019.

MLA (9th ed.) Citation

Rajesh K. Kasam, et al. Dysregulation of Mesenchymal Cell Survival Pathways in Severe Fibrotic Lung Disease: The Effect of Nintedanib Therapy. Frontiers Media S.A., 2019.